A. Angelergues Et Al. , "Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer," EUROPEAN JOURNAL OF CANCER , vol.50, no.9, pp.1602-1609, 2014
Angelergues, A. Et Al. 2014. Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer. EUROPEAN JOURNAL OF CANCER , vol.50, no.9 , 1602-1609.
Angelergues, A., Maillet, D., Flechon, A., Ozguroglu, M., Mercier, F., Guillot, A., ... Le Moulec, S.(2014). Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer. EUROPEAN JOURNAL OF CANCER , vol.50, no.9, 1602-1609.
Angelergues, Antoine Et Al. "Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer," EUROPEAN JOURNAL OF CANCER , vol.50, no.9, 1602-1609, 2014
Angelergues, Antoine Et Al. "Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer." EUROPEAN JOURNAL OF CANCER , vol.50, no.9, pp.1602-1609, 2014
Angelergues, A. Et Al. (2014) . "Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer." EUROPEAN JOURNAL OF CANCER , vol.50, no.9, pp.1602-1609.
@article{article, author={Antoine Angelergues Et Al. }, title={Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer}, journal={EUROPEAN JOURNAL OF CANCER}, year=2014, pages={1602-1609} }